Acasti pharma awarded composition-of-matter patents for gtx-101 in europe, china and mexico and for gtx-102 in japan

Patents strengthen acasti's ip portfolio and provide protection through 2036 and 2037, respectively patents strengthen acasti's ip portfolio and provide protection through 2036 and 2037, respectively

ACST Ratings Summary

ACST Quant Ranking